Ligand validation:5AFM

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5AFM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5AFM_NAG_C_301	68%	24%	0.105	0.927	1.4	1.68	3	5	1	0	93%	0.9333
5AFM_NAG_D_301	58%	18%	0.139	0.931	1.31	2.23	2	5	5	0	93%	0.9333
5AFM_NAG_E_301	57%	28%	0.147	0.936	1.25	1.63	3	4	6	0	93%	0.9333
5AFM_NAG_E_302	33%	18%	0.171	0.863	1.59	1.95	4	4	3	0	93%	0.9333
5AFM_NAG_B_301	29%	27%	0.183	0.853	1.3	1.61	3	5	3	0	93%	0.9333
5AFM_NAG_A_301	23%	24%	0.199	0.836	1.35	1.73	3	5	4	0	93%	0.9333
5AFM_NAG_A_302	20%	19%	0.22	0.831	1.55	1.91	4	4	2	0	93%	0.9333
5AFM_NAG_D_302	7%	19%	0.287	0.761	1.54	1.91	3	4	3	0	93%	0.9333
5AFM_NAG_B_302	4%	15%	0.302	0.696	1.71	2.07	6	4	2	0	93%	0.9333
5AFM_NAG_C_302	2%	17%	0.332	0.642	1.59	1.97	4	4	1	0	93%	0.9333
4HQP_NAG_B_803	28%	66%	0.241	0.893	0.69	0.63	-	-	1	0	100%	0.9333
3SQ6_NAG_H_901	13%	53%	0.264	0.805	0.95	0.86	1	1	2	0	100%	0.9333
3SQ9_NAG_B_901	10%	41%	0.213	0.715	1.1	1.21	2	1	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.83	0.93	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	100%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.